Whilst I agree the likely hood of a CR occurring increases each day, heres 6 reasons why a CR may not be 100% guaranteed:
1 - AnteoTech receives a grant/s for circa $4 Million. The last CR was for $4 (SI's) and I suspect that this would have been part of the application process for a 1:1 grant under the Queensland Critical Minerals and Battery Technology Fund. Maybe AnteoTech get the full $2M there.
The following may (or may not) help to explain why the CR was done when it was, why there was a delay in commencing construction and why the company hasn't provided details of an opening date.
https://edge.sitecorecloud.io/giclimited1-qiccom-prod-94af/media/Project/QIC/QIC/About-QIC/GuidelinesforCriticalMineralsandBatteryTechnologyFund_July-2023.pdfNote: If we do get funding under this fund then it sounds like we would also get our day in the sun. ie
"The State reserves the right to be the first to announce successful outcomes. In some instances, successful recipients will be required to be involved in media events and erect signage acknowledging the government’s contribution. Media enquiries or public announcements will be managed by Queensland Treasury’s media team in consultation with successful recipients"..........................................................
Then perhaps there is another $1M for each of the two anode iterations being (i) Consumer electronics, and (ii) Storage Systems. I assume that the application would have been a similar process
The company went from stating "
we have applied for three grants but theres not a lot more we can say" to "
we have applied for a grant in consumer electronics and storage systems and if we were to get a grant that would be an endorsement of the company and its tech" (or something along those lines).
2 - $4.5Million in options get converted. The last CR included 71.4 million unlisted options with an exercise price of 6.4 cents. Obviously there would need to be a trigger to push the share price north of 6.4c but if it is good enough for AnteoTech to include this as a possibility in their September 2023 4c then its good enough for me to consider it a possibility. Obviously not all options would be converted straight away, but I could see the directors and larger holders converting early.
3 - The company signs a deal with Trinseo/Wyon. AnteoTech went from having "t
welve high priority targets" (25.10.23) to
"10 high value customer opportunities" (28.02.24). Trinseo and Wyon may have been terminated but there is also the possibility that the contracts have been closed, pending the opening on the pilot plant (not sure if thats even possible). DR did say early last year that the contract with Trinseo would include off take so an upfront pre-payment for AnteoX could be a possibility.
4 - The company signs a deal with the Serum institute of India. In the latest webinar DR said that AnteoTech was at advanced stage negations and has previously stated that the contracts being negotiated were meaningful.
5 - The company signs a contract with Merck etc for the the supply of Anteobind NXT. AnteoTech was meant to sign a contract for Anteobind mid last year but that got pushed back to first half of CY2024 for no specific reason as to why. Maybe that reason was NXT which they have now finalised.
6 - EV1 likes what they see at takes an equity stake. Probably highly unlikely but still a possibly.
With all that said, the above would need to happen fairly quickly and prior to the next 4c.
